Cargando…
Differentiation of Human Mesenchymal Stem Cells from Wharton’s Jelly Towards Neural Stem Cells Using a Feasible and Repeatable Protocol
The transplantation of neural stem cells (NSCs) capable of regenerating to the cells of the central nervous system (CNS) is a promising strategy in the treatment of CNS diseases and injury. As previous studies have highlighted mesenchymal stem cells (MSCs) as a source of NSCs, this study aimed to de...
Autores principales: | Kruminis-Kaszkiel, Ewa, Osowski, Adam, Bejer-Oleńska, Ewa, Dziekoński, Mariusz, Wojtkiewicz, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140706/ https://www.ncbi.nlm.nih.gov/pubmed/32192154 http://dx.doi.org/10.3390/cells9030739 |
Ejemplares similares
-
The Current State of Osteoarthritis Treatment Options Using Stem Cells for Regenerative Therapy: A Review
por: Thoene, Michael, et al.
Publicado: (2023) -
Can Youthful Mesenchymal Stem Cells from Wharton’s Jelly Bring a Breath of Fresh Air for COPD?
por: Janczewski, Andrzej M., et al.
Publicado: (2017) -
CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
por: Kruminis-Kaszkiel, Ewa, et al.
Publicado: (2018) -
The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019) -
AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)